Armistice Capital »

Biovie shares owned by Armistice Capital

Quarter-by-quarter ownership of Biovie (BIVIW) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Biovie

Tip: Access up to 7 years of quarterly data

All positions including Biovie held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biovie by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $155k 500k 0.31

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding Biovie

Diametric Capital
Armistice Capital
Warberg Asset Management
Springbok Capital Management
MYDA Advisors
Heights Capital Management
Armstrong Advisory Group
Two Sigma Securities

View all funds holding Biovie